GlassScriptPhysician profile
Ann M Romaker
NPI 1386621548
$1,585.25
in general payments reported to CMS, 2019-2025
22 companies · $480 in 2025
The $480 reported for 2025 was more than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $24.60 · 2021: $17.01 · 2022: $128 · 2023: $284 · 2024: $652 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,236 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,235.76 |
| Education | $179.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $323.31 | 2021-2025 | |
| Glaxosmithkline, LLC. | $269.16 | 2022-2025 | Nucala, Shingrix, Arexvy |
| Harmony Biosciences LLC | $235.80 | 2020-2025 | |
| Inspire Medical Systems, INC. | $201.82 | 2023-2025 | Inspire |
| Baxter Healthcare | $79.90 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Genzyme Corporation | $57.33 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $56.05 | 2024 | Glassia |
| Mallinckrodt Hospital Products INC. | $52.50 | 2023-2024 | Acthar |
| Fisher & Paykel Healthcare INC | $45.81 | 2024 | Fisher & Paykel Healthcare |
| Philips North America LLC | $44.21 | 2025 | Vest Therapy Und |
| Merck Sharp & Dohme LLC | $27.70 | 2024 | Winrevair |
| Avadel Cns Pharmaceuticals, LLC | $20.51 | 2024 | Lumryz |
| United Therapeutics Corporation | $19.82 | 2024 | Orenitram, Remodulin |
| Regeneron Healthcare Solutions, INC. | $19.15 | 2025 | Dupixent |
| Alcresta Therapeutics, INC. | $18.77 | 2024 | Relizorb |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $18.40 | 2024 | Arikayce |
| Axsome Therapeutics, INC. | $17.53 | 2025 | Sunosi |
| Pfizer INC. | $16.10 | 2025 | |
| Inogen, INC. | $15.70 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Azurity Pharmaceuticals, INC. | $15.57 | 2024 | Horizant |
| Itamar Medical INC | $15.42 | 2024 | Watchpatone |
| Bayer Healthcare Pharmaceuticals INC. | $14.69 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Romaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.